Accelerating Innovation at Leica Biosystems

Accelerating Capacity Expansion Plans PLANNED BIOPROCESSING MFG. CAPITAL EXPENDITURES 2021 & 2022 $200M $600M Other Chromatography Resins $1.5B $300M SUT TOTAL +>2,000 ANTICIPATED ASSOCIATE NEW-HIRES NEXT 2 YEARS Artua cha Cell Culture Media $400M Ongoing capacity investments driving share gains DANAHER

View entire presentation